MRP: ₹2909
₹2471
₹ 438 Off
(Incl. of all taxes)
Qty
Buying in bulk?
In stock
Deliver to
- 7-day returns
- Secure payment
- International shipping
- Carefully packed
Get this at ₹ 2347Extra 5% OffAdd items worth ₹999 to the cart & get extra 5% off
Get this at ₹ 2224Extra 10% OffAdd items worth ₹1499 to the cart & get extra 10% off
Book Summary
-- Addresses the introduction of Betaseron as the first drug approved by the FDA
for treatment of some patients with MS
-- Assesses the results of new clinical trials with other interferons, Cop-1,
and oral myelin
-- Contains expanded information on the use of antidepressants, such as Prozac,
to combat psychological effects
-- Discusses laws that help individuals with MS avoid discrimination in
employment
-- Outlines recent findings in epidemiology and genetics
-- Includes patient resources
- ISBN-13
- 9780803600744
- Language
- English
- Binding
- Paper Back
- Publisher
- F. A. Davis
- Publishing Date
- 1995
- Product Edition
- 2 Rev ed
- Total Pages
- 235
Multiple Sclerosis Fact Book
Frequently bought together
Total for 3 items₹2597₹3049You save ₹452
Product Specifications
Book Summary
-- Addresses the introduction of Betaseron as the first drug approved by the FDA
for treatment of some patients with MS
-- Assesses the results of new clinical trials with other interferons, Cop-1,
and oral myelin
-- Contains expanded information on the use of antidepressants, such as Prozac,
to combat psychological effects
-- Discusses laws that help individuals with MS avoid discrimination in
employment
-- Outlines recent findings in epidemiology and genetics
-- Includes patient resources
Book Specifications
- ISBN-13
- 9780803600744
- Language
- English
- Binding
- Paper Back
- Publisher
- F. A. Davis
- Publishing Date
- 1995
- Product Edition
- 2 Rev ed
- Total Pages
- 235